Senores Pharmaceuticals Limited (SPL) has acquired the USFDA-approved Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg and 500 mcg tablets from Breckenridge Pharmaceutical, Inc., a subsidiary of Towa International. This agreement was executed through its wholly-owned US subsidiary, Senores Pharmaceuticals, Inc. IPO Proceeds Used for Acquisition The acquisition is being funded through SPL’s IPO …